Save time and jump to the most important pieces.
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
SC 13G/A - Chromocell Therapeutics Corp (0001919246) (Subject)
SC 13G - Chromocell Therapeutics Corp (0001919246) (Subject)
SC 13G - Chromocell Therapeutics Corp (0001919246) (Subject)
Alliance Global Partners analyst James Molloy initiates coverage on Chromocell Therapeutics (AMEX:CHRO) with a Buy rating.
Gainers Innovative Eyewear (NASDAQ:LUCY) stock increased by 173.2% to $1.12 during Wednesday's regular session. The market value of their outstanding shares is at $19.6 million. Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 53.94% to $0.32. The company's market cap stands at $7.5 million. Sonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 34.56% to $0.27. The company's market cap stands at $4.2 million. Apollomics (NASDAQ:APLM) shares increased by 28.89% to $0.34. The market value of their outstanding shares is at $36.7 million. Onconetix (NASDAQ:ONCO) shares moved upwards by 25.07% to $0.2. The market value of their outstanding shares is at $4.5 million. Chromocell Therapeuti
Gainers CareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.62. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. Macrogenics (NASDAQ:MGNX) stock rose 27.79% to $4.23. The market value of their outstanding shares is at $264.6 million. As per the news, the Q1 earnings report came out 2 days ago. Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 25.68% to $2.3. The market value of their outstanding shares is at $13.5 million. Omega Therapeutics (NASDAQ:OMGA) shares moved upwards b
8-K - Channel Therapeutics Corp (0001919246) (Filer)
8-K12G3 - Channel Therapeutics Corp (0001919246) (Filer)
8-K - Channel Therapeutics Corp (0001919246) (Filer)
"Channel Therapeutics" reflects the Company's focus on developing therapeutics to treat pain utilizing sodium channel blockade and modulationNew name is in advance of multiple near-term data readouts FREEHOLD, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation, (NYSE:CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that on November 18, 2024 it had changed its name to Channel Therapeutics Corporation ("Channel" or the "Company"), along with reincorporating in the State of Nevada. The Company believes the name change better reflects its focus on developing therapeutics based on sodium channel modulation and blockade for
FREEHOLD, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation ("Chromocell", or the "Company"), (NYSE:CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced the unveiling of its injectable depot program utilizing peripheral nerve blocks for the treatment of post-operative pain. The depot program is based on the Company's novel NaV1.7 molecule for treating chronic pain and eye pain. There are approximately 700,000 total knee replacements and 500,000 shoulder arthroplasties performed annually in the Unites States for which this analgesic modality might be applicable, providing a robust potential market for the product. "We are
FREEHOLD, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation ("Chromocell", or the "Company"), (NYSE:CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that Frank Knuettel II, CEO, will present at the upcoming LDMicro and Spartan Capital investor conferences. Details for the conferences and presentations are as follows: LDMicro Main Event XVII (October 28-30, 2024) Presentation: October 29, 2024 Time: 10:00 AM - 10:25 AM PTLocation: Luxe Sunset BLVD Hotel, Los AngelesIn-person registration: LINKVirtual attendance: LINKAvailable for 1x1 meetings: October 29th The Main Event has become the industry stand